Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02880371 |
|---|---|
| Brief Title: | A Study of ARRY-382 in Combination With Pembrolizumab for the Treatment of Patients With Advanced Solid Tumors |
| First Submitted : | August 2, 2016 |
| First Submitted that Met QC Criteria : | August 23, 2016 |
| First Posted : | August 26, 2016 (Estimate) |
| Results First Submitted : | April 4, 2022 |
| Results First Submitted that Met QC Criteria : | May 21, 2022 |
| Results First Posted : | June 16, 2022 |
| Last Update Submitted that Met QC Criteria : | May 21, 2022 |
| Last Update Posted : | June 16, 2022 |